TMO Thermo Fisher Scientific, Inc.

276.545.52 (+2.04%)
IEX real time price: 10:12:45 AM

Quote

Previous Close
$271.02
Day Range
$272.41-$276.20
52 Week Range
$202.83-$282.98
Volume
152,695
Avg Volume
1,821,429
Dividend TTM
$0.70 (0.26%)
Ex-Dividend Date
2019-03-14

Valuation

Market Cap
$110.61B
Enterprise Value (EV)
$125.53B
PE Ratio
35.02
EV/EBITDA
20.45
Price/Sales
4.46
Price/Book
3.93
PEG Ratio
2.77

Financials

Revenue
$24.36B
Gross Profit
$10.99B
EBITDA
$6.14B
EPS, ttm
$7.90
Profit Margin
12.06%
Revenue/Employee
$347.97K
Next Earnings Date
7/24/2019 (61 days)
Debt to Equity
69%
Debt
$17.04B
Cash
$2.12B
Net Debt
$14.92B

Performance

Beta
1.15
200 Day Moving Avg
$246.35
50 Day Moving Avg
$270.11
52 Week Change
25.49%
YTD Change
25.55%
1 Month Change
3.62%
3 Month Change
6.77%
6 Month Change
12.84%
1 Year Change
25.49%
2 Year Change
63.72%
5 Year Change
139.57%

Share Count

Shares Outstanding
400.0M
Float
398.0M
Restricted Shares
2.0M
Restricted Shares, %
0.50%

Thermo Fisher Scientific, Inc. Company Details

Sector: Health Technology

Industry: Medical Specialties

CEO: Marc N. Casper

Website: http://www.thermofisher.com

Description: Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded in November 2006 and is headquartered in Waltham, MA.

Employees: 70,000